Loss-of-function of <i>BRM</i> results in changes of H3K27me3 distribution over several hundred endogenous genes. by Chenlong Li (585884)

“…Nine of them showed an increase and one showed a decrease in H3K27me3 levels. Data for the wild-type Col are shown in red at the top, and <i>brm-1</i> is shown in orange at the bottom. …”

Image_1_Artificial intelligence-based 68Ga-DOTATOC PET denoising for optimizing 68Ge/68Ga generator use throughout its lifetime.TIF by Elske Quak (4054948)

“…Introduction<p>The yield per elution of a ⁶⁸Ge/⁶⁸Ga generator decreases during its lifespan. …”

Table_5_Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients.docx by Javier David Benitez Fuentes (14281331)

“…The patients with decreased cellular response after the booster had a higher expression of PD1⁺CD8⁺ and CD57⁺PD1⁺CD8⁺ exhausted T cells compared with those with an increased cellular response both in vivo and in vitro. …”

Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination by Christiane Costa-Pereira (5348894)

“…<div><p>In this investigation, machine-enhanced techniques were applied to bring about scientific insights to identify a minimum set of phenotypic/functional memory-related biomarkers for post-vaccination follow-up upon yellow fever (YF) vaccination. …”

Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Bias risk assessment for individual studies. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Sustained-release of phages targets <i>E</i>. <i>faecalis</i> biofilm. by Mor Shlezinger (4897351)

“…<p><b>(A) <i>E</i>. <i>faecalis</i> biofilm biomass decreased following treatment with sustained-release EFDG1/EFLK1 phage cocktail.…”

Data_Sheet_2_Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer A... by Gurbet Tutumlu (8691720)

“…In the first approach, a molecular docking and filtering approach is used to rank compounds based on their docking scores and only a few top-ranked molecules are selected for further long (100-ns) molecular dynamics (MD) simulations and in vitro tests. …”

The Effect of Symmetric and Asymmetric NHCs on the Structure and Catalytic Properties of Dialkylgallium Alkoxides in the Ring-Opening Polymerization of <i>rac</i>-LactideLinking t... by Anna Maria Dąbrowska (1859476)

“…The much smaller cavity of <b>4</b> led to a minor activity and lower isoselectivity (<i>P</i>_m‑max = 0.56 at −20 °C). …”

Expression of mesoderm and primitive streak markers in <i>Cul4b</i>-null embryos. by Chun-Yu Chen (486495)

“…(C, D) A slight decrease in Brachyury was detected at E7.5 in <i>Cul4b</i>^<i>Δ/</i><i>Y</i> embryos. …”

Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Subgroup analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Retinoic acid signaling responsiveness in the periocular region. by Glenda Evangelina Comai (9652709)

“…BMS493 treatment before and after tamoxifen induction reveals a drastic decrease in GFP+ cells in the periocular region (<b>I</b>) compared with controls (<b>G</b>). …”

Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla by Mette Thrane Foged (4050703)

“…The degree of artifacts and the ability to identify background activity was assessed by visual analysis by a trained expert in the 64 channel EEG data (7 healthy controls, 13 patients).…”

Meta-analysis off requency of angina attacks. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”

Flow of patients in Halos trial. by Bruno Martins Tomazini (6509528)

“…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”

Meta-analysis of angina pectoris attack time. by Xiaoqi Wu (9503481)

“…<div><p>Objective</p><p>To systematically evaluate the efficacy and safety of Sodium tanshinone ⅡA sulfonate injection (STS) in the treatment of unstable angina pectoris (UAP).…”